Abstract Meta-analyses suggest normalizing effects of methylphenidate on structural fronto-striatal abnormalities in patients with attention-deficit/hyperactivity disorder (ADHD). A subgroup of patients receives atypical antipsychotics concurrent with methylphenidate. Long-term safety and efficacy of combined treatment are unknown. The current study provides an initial investigation of structural brain correlates of combined methylphenidate and antipsychotic treatment in patients with ADHD. Structural magnetic resonance imaging was obtained in 31 patients who had received combined methylphenidate and antipsychotic treatment, 31 matched patients who had received methylphenidate but not antipsychotics, and 31 healthy controls (M age 16.7 years). We analyzed between-group effects in total cortical and subcortical volume, and in seven frontal cortical and eight subcortical-limbic volumes of interest, each involved in dopaminergic neurotransmission. Patients in the combined treatment group, but not those in the methylphenidate only group, showed a reduction in total cortical volume compared to healthy controls (Cohen’s d = 0.69, p < 0.004), which was apparent in most frontal volumes of interest. Further, the combined treatment group, but not the methylphenidate group, showed volume reduction in bilateral ventral diencephalon (Left Cohen’s d = 0.48, p < 0.04; Right Cohen’s d = 0.46, p < 0.05) and the left thalamus (Cohen’s d = 0.47, p < 0.04). These findings may indicate antipsychotic treatment counteracting the normalizing effects of methylphenidate on brain structure. However, it cannot be ruled out that pre-existing clinical differences between both patient groups may have resulted in anatomical differences at the time of scanning. The absence of an untreated ADHD group hinders unequivocal interpretation and implications of our findings.
methylphenidate     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Methylphenidate       

anatomical                    0.9999885898019554^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Neuroanatomy          

antipsychotic                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Antipsychotic         

Meta-analyses                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Meta-analysis         

efficacy                      0.9999999999956799^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Efficacy              

ADHD                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Attention_deficit_hyperactivity_disorder

methylphenidate               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Methylphenidate       

methylphenidate               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Methylphenidate       

methylphenidate               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Methylphenidate       

antipsychotics                1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Antipsychotic         

safety                        0.999194053082519^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Safety                

frontal                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Frontal_lobe          

thalamus                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Thalamus              

magnetic resonance imaging    0.9639642534572693^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Functional_magnetic_resonance_imaging

methylphenidate               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Methylphenidate       

concurrent                    0.8623776241583363^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Concurrency_(computer_science)

subgroup                      0.9350130294328818^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Subgroup              

methylphenidate               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Methylphenidate       

cortical                      0.9997788804222647^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cerebral_cortex       

methylphenidate               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Methylphenidate       

antipsychotic                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Antipsychotic         

antipsychotic                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Antipsychotic         

frontal                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Frontal_lobe          

brain                         0.9997106134807758^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Brain                 

ADHD                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Attention_deficit_hyperactivity_disorder

attention-deficit/hyperactivity disorder1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Attention_deficit_hyperactivity_disorder

neurotransmission             0.9999977853373788^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Neurotransmitter      

methylphenidate               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Methylphenidate       

atypical antipsychotics       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Atypical_antipsychotic

treatment group               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Treatment_and_control_groups

treatment group               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Treatment_and_control_groups

bilateral                     0.9999999998849489^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Anatomical_terms_of_location

ventral                       0.7412043733643199^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Anatomical_terms_of_location

ADHD                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Attention_deficit_hyperactivity_disorder

dopaminergic                  0.9949725173792353^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Dopaminergic          

diencephalon                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Diencephalon          

cortical                      0.9997788804222647^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cerebral_cortex       

brain                         0.9997106134807758^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Brain                 

cortical                      0.9997788804222647^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cerebral_cortex       

